
Comprehensive translational in-vivo disease models designed to accelerate
drug discovery, efficacy studies, target validation and IND-enabling studies
across multiple therapeutic areas.
Advanced inflammatory disease models for gastrointestinal, pulmonary,
dermatological and autoimmune disorders.
Validated gastrointestinal inflammatory models for IBD and Crohn’s disease research.
Translational skin inflammation models supporting psoriasis and fibrosis studies.
Respiratory inflammation models supporting COPD, asthma and fibrosis programs.
Clinically relevant models for rheumatoid arthritis and osteoarthritis research.
Acute and chronic pain models designed to support analgesic drug discovery.
CNS and neurodegenerative disease models supporting translational neuroscience research.
Translational metabolic disease models for diabetes and obesity research.
Preclinical renal disease models supporting nephrology drug development.
Oncology models supporting IND-enabling studies and anticancer drug development.
Regenerative medicine and tissue repair models supporting wound therapeutics.
Translational fibrosis models supporting anti-fibrotic drug discovery.